Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001387131-20-001265
Filing Date
2020-02-11
Accepted
2020-02-11 07:45:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tnxp-424b4_021020.htm 424B4 2579507
2 GRAPHIC tnxp001.jpg GRAPHIC 4585
3 GRAPHIC tnxp002.jpg GRAPHIC 4181
  Complete submission text file 0001387131-20-001265.txt   2592913
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1220
Type: 424B4 | Act: 33 | File No.: 333-235976 | Film No.: 20593930
SIC: 2834 Pharmaceutical Preparations